Ametek (AME) FY2025 10-K Annual Report
Ametek (AME) 10-K annual report for fiscal year 2025, filed with SEC EDGAR on Feb 17, 2026. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.
Ametek FY2025 10-K Analysis
Business Overview
- • Core business: global manufacturing of electronic instruments and electromechanical devices for industrial, aerospace, medical markets
- • New emphasis on AI tools in product development improving pace and quality of innovations in 2025
- • Strategic shift toward more highly differentiated businesses via acquisitions, with 15 deals totaling $1.8B in annual sales since 2021
- • Employee count not disclosed, but expanded global manufacturing footprint including facilities in China, Czechia, Malaysia, Mexico, Serbia
- • Record 2025 operating and financial performance driven by organic growth, acquisitions, and Operational Excellence initiatives
Management Discussion & Analysis
- • Revenue $7,401.1M, up 6.6% YoY from $6,941.2M; EIG sales up 5.6%, EMG sales up 8.8%
- • Operating income $1,910.3M, up 7.3%; operating margin 25.8% vs 25.6% YoY
- • Best segment EMG revenue $2,482.0M (+8.8%), worst EIG lower growth $4,919.1M (+5.6%)
- • Acquisition costs $37.3M pre-tax; interest expense down 28.1% to $81.3M; no capex/buyback/dividend data
- • Backlog a record $3,581.5M, up 5.2%; management notes margin impact from acquisitions and integration costs
Risk Factors
- • United States government tariffs on imports, potential adverse impact on costs and demand, situation evolving but no material 2025 effect reported
- • Exposure to global supply chain disruptions mitigated by geographic manufacturing footprint and strategic supply adjustments
- • Acquisition of FARO Technologies for $933.2 million expands 3D measurement/imaging solutions, integration risk amid competitive tech market
- • Share repurchases of $443.0 million for 2.3 million shares in 2025 raises leverage and capital allocation scrutiny
- • High R&D investment at $382.8 million with 27% of sales from products introduced within three years, critical for market competitiveness
Ametek FY2025 Key Financial MetricsXBRL
Revenue
$7.4B
▲ +6.6% YoY
Net Income
$1.5B
▲ +7.6% YoY
Operating Margin
25.8%
▲ +17bp YoY
Net Margin
20.0%
▲ +17bp YoY
ROE
13.9%
▼ -33bp YoY
Total Assets
$16.1B
▲ +9.8% YoY
EPS (Diluted)
$6.40
▲ +7.9% YoY
Operating Cash Flow
$1.8B
▼ -1.5% YoY
Source: XBRL data from Ametek FY2025 10-K filing on SEC EDGAR. All figures in USD.
Get deeper insights on Ametek
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.